Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).
- DOI
- 10.1371/journal.pmed.1004472
- Published
- 2025 May
- Container
- PLoS medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1371/journal.pmed.1004472,
title = {Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).},
author = {Halbherr S and Lerch S and Bellwald S and Polakova P and Bannert B and Roumet M and Charles RP and Walter MA and Bernasconi C and Halbherr VL and Peitsch C and Baumgartner PC and Kaufmann C and Aires V and Mattle HP and Kaelin-Lang A and Hartmann A and Schuepbach M},
year = {2025},
journal = {PLoS medicine},
doi = {10.1371/journal.pmed.1004472},
url = {https://doi.org/10.1371/journal.pmed.1004472}
}RIS
TY - JOUR TI - Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial). AU - Halbherr S AU - Lerch S AU - Bellwald S AU - Polakova P AU - Bannert B AU - Roumet M AU - Charles RP AU - Walter MA AU - Bernasconi C AU - Halbherr VL AU - Peitsch C AU - Baumgartner PC AU - Kaufmann C AU - Aires V AU - Mattle HP AU - Kaelin-Lang A AU - Hartmann A AU - Schuepbach M PY - 2025 JO - PLoS medicine DO - 10.1371/journal.pmed.1004472 UR - https://doi.org/10.1371/journal.pmed.1004472 ER -
APA
S, H., S, L., S, B., P, P., B, B., M, R., RP, C., MA, W., C, B., VL, H., C, P., PC, B., C, K., V, A., HP, M., A, K., A, H., & M, S. (2025). Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).. PLoS medicine. https://doi.org/10.1371/journal.pmed.1004472
Source records
- pubmed · retrieved 2026-09-25T07:22:19.498Z
- europe-pmc · retrieved 2026-09-25T07:22:19.475Z
- doaj · retrieved 2026-09-25T07:22:19.499Z